Ironwood Pharmaceuticals Changes Certifying Accountant
Ticker: IRWD · Form: 8-K · Filed: Jul 10, 2025 · CIK: 1446847
| Field | Detail |
|---|---|
| Company | Ironwood Pharmaceuticals Inc (IRWD) |
| Form Type | 8-K |
| Filed Date | Jul 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, administrative
TL;DR
Ironwood Pharma swapped auditors, effective July 3rd.
AI Summary
Ironwood Pharmaceuticals, Inc. filed an 8-K on July 10, 2025, reporting a change in its certifying accountant as of July 3, 2025. The company, headquartered in Boston, MA, is a pharmaceutical preparations company.
Why It Matters
A change in a company's auditor can sometimes signal underlying financial concerns or a desire for a fresh perspective on financial reporting.
Risk Assessment
Risk Level: low — This filing reports a routine administrative change in the company's auditor, which typically carries low risk.
Key Players & Entities
- Ironwood Pharmaceuticals, Inc. (company) — Registrant
- July 3, 2025 (date) — Date of Earliest Event Reported
- July 10, 2025 (date) — Date of Report
- Boston, Massachusetts (location) — Principal Executive Offices
FAQ
What is the specific reason for the change in Ironwood Pharmaceuticals' certifying accountant?
The filing does not specify the reason for the change in certifying accountant, only that it occurred as of July 3, 2025.
Who is the new certifying accountant for Ironwood Pharmaceuticals?
The filing does not disclose the name of the new certifying accountant.
Was there any disagreement with the previous certifying accountant?
The filing does not mention any disagreements with the previous certifying accountant.
When was the change in certifying accountant effective?
The change in certifying accountant was effective as of July 3, 2025.
What is Ironwood Pharmaceuticals' primary business?
Ironwood Pharmaceuticals, Inc. is in the business of pharmaceutical preparations, as indicated by its SIC code [2834].
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 10, 2025 regarding IRONWOOD PHARMACEUTICALS INC (IRWD).